The directorate is looking for experts to join the European Pharmacopoeia network.
The European Directorate for the Quality of Medicines and Healthcare (EDQM) is opening up its network of pharmaceutical sciences experts to non-European Pharmacopoeia member states and non-observer states in preparation for the publication of the 10th edition of the European Pharmacopoeia (Ph. Eur.). The network, which is made up of more than 700 pharmaceutical experts, contributes their knowledge to the development of the monographs and texts in the Ph. Eur.
The invitation is a result of the increased globalization of the pharmaceutical industry. “This decision is part of a deliberate policy to further involve manufacturers and other stakeholders from outside Europe in the work of the European Pharmacopoeia. Experts from all around the world, whether they are from authorities, industry or academia, will be able to contribute to the preparation of the 10th Edition,” EDQM states in a press release.
Ph. Eur. members interested in becoming a member should submit their candidature to the National Pharmacopoeia Authorities. Candidates from non Ph. Eur. member states should contact the Secretariat.
Source:
EDQMEMA Recommends Imfinzi-Based Perioperative Regimen for Treating Resectable NSCLC
March 10th 2025The committee’s recommendation is based on results from a Phase III trial in which Imfinzi demonstrated a reduced risk of recurrence, progression, or death by 32% compared to neoadjuvant chemotherapy alone.
International Women’s Day 2025: A Promising Future for Gender Diversity in Pharma
March 8th 2025In an interview with BioPharm International®, Sheryl Johnson from Orbia Fluor & Energy Materials chats about gender diversity, how women are helping to advance innovation, sustainability challenges, and progress in the field of inhaled drugs.